SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-032029
Filing Date
2022-05-26
Accepted
2022-05-26 08:28:34
Documents
2
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2948
2 POA DOCUMENT poa.txt EX-24 3276
  Complete submission text file 0001209191-22-032029.txt   7594
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDOS BIOPHARMA, INC. 1800 KRAFT DRIVE, SUITE 216 BLACKBURG VA 24060
Business Address
Truesdell Patrick (Reporting) CIK: 0001930771 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39971 | Film No.: 22965594